I have no idea what the company is going to say, or who they're going to say it to. If an approval is simply announced but essentially ignored by the mass media, then as some have said, the reaction may not be that great, though I still believe it's worth at least a $2 billion market cap.
On the other hand, if behind the scenes our PR people and CEO have been speaking with major media outlets, under confidentiality, so that when we get approval, major media has stories about a new paradigm for the treatment of cancer, that could be a very different story.
If you've ever seen a company move up on major media news, you really never know just how high it can go. I know people who won't touch NWBO at $.25 who'd buy at $5 or more from the headlines. Just as most Institutions charters require higher prices, many at $5 or more, many small investors do the same. That would be a 20 banger from where we are today, but many people view penny stocks like they're worthless.
I have 10K shares of a stock that's frequently been at $10 or more, I do believe in a year or two it has the potential to go to $100 or more, but $1000 while possible, would take a decade or more.
On the other hand, at $.25 I believe NWBO can easily go to $2.50, it might do it in a day. Then there is $25, very possible in a year or so. How about $250, if a tumor agnostic label is achieved or DCVax-Direct is approved tumor agnostic, it's certainly in the realm of possibilities.
Gary
Bullish
Market Data 
Markets 
